{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Ftheidi.simplecast.com%2Fepisodes%2Fhealth-equity-and-pharma-where-to-begin-NpR8QHVz","width":444,"version":"1.0","type":"rich","title":"Health Equity and Pharma: Where to Begin?","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9660dd78-6154-402f-87c9-4f85da5cd51a/0d2a0f98-2268-4f07-93dc-0f411170596e/masthead-square-the-idi.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3bb5a304-c78e-4851-8056-62e5b124c179\" height=\"200\" width=\"100%\" title=\"Health Equity and Pharma: Where to Begin?\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"The pharmaceutical industry wants to do the right thing and address health equity. But figuring out what to do first is proving to be a challenge. Tony Gibson, a Principal at Valuate Health, shares his thoughts on how pharma can meaningfully address health equity."}